DIAGNOS Inc. (DGNOF)
OTCMKTS · Delayed Price · Currency is USD
0.1900
+0.0067 (3.66%)
Aug 22, 2025, 4:00 PM EDT
DIAGNOS Market Cap
DIAGNOS has a market cap or net worth of $19.14 million as of August 22, 2025. Its market cap has increased by 2.59% in one year.
Market Cap
19.14M
Enterprise Value
19.75M
Revenue
63.43K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since November 30, 2000, DIAGNOS's market cap has decreased from 24.36M to 19.14M, a decrease of -21.42%. That is a compound annual growth rate of -0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 19.14M | 1.58% |
| Dec 31, 2024 | 18.85M | -17.35% |
| Dec 29, 2023 | 22.80M | 58.65% |
| Dec 30, 2022 | 14.37M | -22.60% |
| Dec 31, 2021 | 18.57M | -38.89% |
| Dec 31, 2020 | 30.39M | 319.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 367.18M |